RSV-F + influenza vaccine (Novavax)

N/A

Report date: 2025/01/26 16:17:49

Base Information

Drug NameRSV-F + influenza vaccine (Novavax)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionRespiratory syncytial virus F protein modulators
TargetsRespiratory syncytial virus F protein
Therapy Area/IndicationsRespiratory Syncytial Virus InfectionsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovavax Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovavax Inc
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus InfectionsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A